Background
==========

Lymphoepithelial carcinoma is an aggressive EBV-associated neoplasm of the nasopharyngeal region. Lymphoepithelioma-like carcinoma (LELC) of the skin, however, is a rare condition \[[@B1]-[@B4]\] and only three cases have been reported in the vulvar region \[[@B5]-[@B7]\]. The same is true for other sites of the female genital tract with some cases described in the uterine cervix \[[@B8]-[@B14]\], two reports each in the ovary \[[@B15]\], the endometrium \[[@B16],[@B12]\], and the vagina \[[@B17],[@B18]\], and only one in the Bartholin gland \[[@B19]\]. In contrast to LELC of the nasopharynx, there is usually no evidence for an association with EBV, but cervical LELC is commonly associated with human papilloma virus \[[@B20]-[@B23]\]. Although LELC is said to be less aggressive in extranasal sites \[[@B1]\], regional lymph node metastases can occur \[[@B24],[@B6]\]. In this case of a 73-year-old woman, a small inguinal metastasis was detected by sentinel node technique.

Case Presentation
=================

Clinical history
----------------

The patient had undergone hysterectomy for uterine leiomyomas 20 years ago. At the age of 62, she had been diagnosed with lobular breast carcinoma. She had received adjuvant radiation and endocrine therapy and there were neither local recurrence nor metastases. A gynaecological check-up at the age of 72 years was without pathological findings, but one year later she consulted her gynaecologist because of a weeping painful vulvar lesion. A slightly elevated and eroded area with a diameter of 1.5 cm was detected, localised at the right minor labium with a minimal distance of 2 mm to the clitoris. A small biopsy showed a non-keratinizing poorly differentiated carcinoma NOS. The patient was hospitalised, preoperative computed tomography of the pelvis was inconspicuous and there were no signs of distant metastases. Ultrasonography showed normal sized inguinal lymph nodes, which were not indurated in physical examination. The surface epithelium apart of the lesion was intact, atrophy or lichenoid changes were not seen, so the clinicians decided for partial vulvectomy. Using sentinel technique before surgical intervention a lymph node could be marked in the right inguinal region. Though the frozen section was negative, one micrometastasis of 1 mm was detected in the paraffin embedded material. The postoperative course was normal. Due to the fact that the histological invasion depth of the tumor did not exceed 2 mm, the patient did not receive adjuvant treatment, but underwent radiaton of the right inguinal region with a focal dose of 5000cGy in 25 fractions because of the lymph node micrometastasis. Nine months after treatment she developed pruritus and scaling which disappeared with local steroid therapy, and at the next follow-up visit only minimal local skin atrophy was visible.

Histopathology and Immunohistochemistry
---------------------------------------

The total specimen measured 6.5:3:1 cm, the margins of resection were inconspicuous, and the oval tumorous lesion itself measured 1.5:1 cm. Histology revealed solid non-keratinizing sheets of tumor cells with high numbers of intraepithelial and stromal lymphocytes (Figure [1](#F1){ref-type="fig"}). The epithelial component did not show squamous or glandular differentiation, so the patient was diagnosed with lymphoepithelial- like carcinoma of the vulva (Figure [2](#F2){ref-type="fig"}). The depth of infiltration measured 2 mm, and there were no signs of angioinvasion or perineural spread. The lesion was completely resected. After processing the sentinel node in a complete series we found one micrometastasis of the same tumor type with a diameter of 1 mm (Figure [3](#F3){ref-type="fig"}). The staging was summarised pT1b, pN1mi(sn), L0, V0, R0, G3.

![**Right minor labium infiltrated by LELC, H&E 100×**.](1746-1596-6-4-1){#F1}

![**LELC, H&E 200×**.](1746-1596-6-4-2){#F2}

![**Micrometastasis of LELC in right inguinal lymph node, H&E 100×**.](1746-1596-6-4-3){#F3}

The antibodies used are listed in Table [1](#T1){ref-type="table"}. EBV was analysed with in-situ hybridisation (ISH) using EBER probe, ready to use, Ventana. Staining for IHC and ISH was processed on Ventana Benchmark automated immunostainer (Ventana Medical Systems Inc. Tucson AZ 85755, USA).

###### 

List of antibodies used for Immunohistochemistry.

  ANTIBODY         CLONALITY           LOT              DILUTION       PRODUCER
  ---------------- ------------------- ---------------- -------------- -------------------------------
  Pancytokeratin   polyclonal rabbit                    1:800          DAKO, Glostrup, Denmark
                                                                       
  CK 5/6           monoclonal mouse    D5/16B4          1:20           DAKO, Glostrup, Denmark
                                                                       
  p63              monoclonal mouse    4A4              ready to use   Ventana, Strasbourg, France
                                                                       
  p16              monoclonal mouse    E6H4             ready to use   mtm labs, Heidelberg, Germany
                                                                       
  CD3              polyclonal rabbit                    1:100          DAKO, Glostrup, Denmark
                                                                       
  CD4              monoclonal mouse    4B12             1:50           DAKO, Glostrup, Denmark
                                                                       
  CD5              monoclonal mouse    4C7              1:100          Novocastra, Newcastle UK
                                                                       
  CD8              monoclonal mouse    C8/144B          1:100          DAKO, Glostrup, Denmark
                                                                       
  CD20             monoclonal mouse    L26              1:600          DAKO, Glostrup, Denmark
                                                                       
  CD138            monoclonal mouse    MI15             1:50           DAKO, Glostrup, Denmark
                                                                       
  TIA-1            monoclonal mouse    TIA-1            1:200          Biocare, CA, USA
                                                                       
  CD56             monoclonal mouse    BC56C04          1:50           Biocare, CA, USA
                                                                       
  Synaptophysin    monoclonal rabbit   SP11             ready to use   Ventana, Strasbourg, France
                                                                       
  Chromogranin     monoclonal mouse    DAK-A3           1:500          DAKO, Glostrup, Denmark
                                                                       
  MLH-1            monoclonal mouse    G168-15          1:50           BD Biosciences, MD, USA
                                                                       
  MSH-2            monoclonal mouse    FE11             1:100          Calbiochem, NJ, USA
                                                                       
  MSH-6            monoclonal mouse    44/MSH6          1:200          BD Biosciences, MD, USA
                                                                       
  HPV              monoclonal mouse    BPV-1/1+CAMVIR   ready to use   Biocare, CA, USA

Immunohistochemistry showed positivity for Cytokeratin 5/6 and p63 indicating basal cell differentiation of the tumor. Wide spectrum cytokeratin did not react as strong and neuroendocrine markers like CD56, Synaptophysin und Chromogranin A were negative. Intraepithelial Lymphocytes were predominantly T-Lymphocytes, strongly staining for CD3, CD5 and CD8 with a positive CD8/CD4 ratio. The stromal lymphocytes mainly reacted positive for CD20, only a few with CD3 and CD8. MLH-1, MSH-2 and MSH-6 had clear nuclear expression. Staining for p16 was evenly strong but HPV was not detected by immunohistochemistry, the in-situ-hybridisation of EBV was negative. IGH and T/gamma rearrangement of the lymphocytic tumor component proved polyclonality.

Discussion
----------

Lymphoepithelioma-like carcinomas in extranasal or extrapharyngeal sites are uncommon tumors, and are rarely diagnosed in the gastrointestinal tract, the breast and the skin. Some scarce reports exist about LELC as a gynaecological neoplasm. LELC differs from its pharyngeal counterparts in some biological characteristics. Whereas the neoplasms of the upper aerodigestive tract are EBV-related, the most cases of LELC described so far were EBV negative \[[@B8]-[@B11]\], especially those in the skin and extracervical gynaecological sites \[[@B20]-[@B23]\]. Only very few reports could figure out a correlation between EBV and LELC of the uterine cervix \[[@B13],[@B14]\]. With a negative EBV in-situ hybridisation this pathway could be excluded for our patient. In the present case histology apart from the main lesion showed intact squamous epithelium, there were no signs of vulvar intraepithelial neoplasia (VIN). Despite of the fact of a strong p16 positivity, immunohistochemistry of HPV was negative. There is some controversy about HPV related LELC \[[@B25],[@B13],[@B14]\], but a few reports give evidence for this possible pathogenesis in the uterine cervix \[[@B8],[@B10]\]. Lichen sclerosus is a further precursor lesion of vulvar carcinoma, but we did not find lichenoid changes in the stromal compartments of the excision specimen. In this case of LELC, tumor associated lymphocytes were typically split up in T-lymphocytes dominating in the intraepithelial component, and B-lymphocytes and some plasma cells in the stromal areas.

Intestinal LELC frequently are microsatellite instable tumors, but normally these patients do not feature a clinical history of hereditary cancer. With strong positivity of MLH1, MSH2 and MSH6 this tumor can be assumed to show microsatellite stability.

Though the lesion was not advanced, one micrometastasis of 1 mm could be detected by sentinel node technique. Lymphoepithelioma-like carcinomas of the skin and the female genital tract are supposed to be associated with a better clinical outcome than their nasal or pharyngeal counterparts \[[@B1]\], but concerning local spread, angioinvasion and lymph node metastasis the results might not be so diverse \[[@B6],[@B24]\]. Lymphoepithelial carcinomas of nasal or pharyngeal origin are sometimes detected by their local lymph node metastases exhibiting only small primaries, so early lymphatic angioinvasion is evident. Except for the present case there were only three reports about vulvar lymphoepithelioma-like carcinomas so far \[[@B5],[@B7]\]. Two of them were locally excised without lymph node staging, and one patient had a long observation period and suffered from advanced disease with well known metastases before treatment \[[@B6]\].

Conclusions
===========

Summarised this could mean that apart from the pathogenesis, malignancy of vulvar LELC might not be so different from lymphoepithelial carcinoma of the nasal tract. Sentinel lymph node technique is appropriate for vulvar carcinomas and gives a good idea about aggressiveness and local spread. In this case of vulvar LELC sentinel technique indicates early metastasising potential, and leaves some reasonable doubts about the consistently maintained favourable outcome of this entity.
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